Screening and identifying the myocardial-injury protective ingredients from Sheng-Mai-San

References

• Bhayana V, Henderson AR. (1995). Biochemical markers of myocardial damage. Clin Biochem 28:1–29
   PubMed Web of Science ®Google Scholar
• Chen X. (1996). Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol Physiol 23:728–32
   PubMed Web of Science ®Google Scholar
• Daugherty A, Dunn JL, Rateri DL, Heinecke JW. (1994). Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94:437–44
   PubMed Web of Science ®Google Scholar
• Deng J, Wang YW, Chen WM, et al. (2010). Role of nitric oxide in ginsenoside Rg1-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats. Biol Pharm Bull 33:631–5
   PubMed Web of Science ®Google Scholar
• Esterbauer H. (1993). Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr 57:779S–85S
   PubMed Web of Science ®Google Scholar
• Fan XH, Wang Y, Cheng YY. (2006). LC/MS fingerprinting of Shenmai injection: A novel approach to quality control of herbal medicines. J Pharm Biomed Anal 40:591–7
   PubMedGoogle Scholar
• Fontes JP, Goncalves M, Ribeiro VG. (1999). Serum markers for ischemic myocardial damage. Rev Port Cardiol 18:1129–36
   PubMedGoogle Scholar
• Galeotti L, Strauss DG, Ubachs JF, et al. (2009). Development of an automated method for display of ischemic myocardium from simulated electrocardiograms. J Electrocardiol 42:204–12
   PubMedGoogle Scholar
• Ghisalberti EL. (1997). Cardiovascular activity of naturally occurring lignans. Phytomedicine 4:151–66
   PubMed Web of Science ®Google Scholar
• Hanninen H, Takala P, Rantonen J, et al. (2003). ST-T integral and T-wave amplitude in detection of exercise-induced myocardial ischemia evaluated with body surface potential mapping. J Electrocardiol 36:89–98
   PubMedGoogle Scholar
• Harrison J, Schultz J. (1976). Studies on the chlorinating activity of myeloperoxidase. J Biol Chem 251:1371–4
   PubMed Web of Science ®Google Scholar
• He F, Guo R, Wu SL, et al. (2007). Protective effects of ginsenoside Rb1 on human umbilical vein endothelial cells in vitro. J Cardiovasc Pharmacol 50:314–20
   PubMedGoogle Scholar
• Jiang WL, Zhang SM, Tang XX, Liu HZ. (2011). Protective roles of cornuside in acute myocardial ischemia and reperfusion injury in rats. Phytomedicine 18:266–71
   PubMedGoogle Scholar
• Kim H, Chen X, Gillis CN. (1992). Ginsenosides protect pulmonary vascular endothelium against free radical-induced injury. Biochem Biophys Res Commun 189:670–6
   PubMedGoogle Scholar
• Li G, Wei ZL, Zheng XL. (2002). Effect of ginsenoside-Rb1 on cardiomyocyte apoptosis after ischemia and reperfusion in rats. J Huazhong Univ Sci Technol (Health Sci) 22:212–15
   Google Scholar
• Li L, Pan Q, Han W, et al. (2007). Schisandrin B prevents doxorubicin-induced cardiotoxicity via enhancing glutathione redox cycling. Clin Cancer Res 13:6753–60
   PubMed Web of Science ®Google Scholar
• Li X, Zhao B, Liu G, Xin W. (1990). Scavenging effects on active oxygen radicals by schizandrins with different structures and configurations. Free Radic Biol Med 9:99–104
   PubMedGoogle Scholar
• Liu Y, Lin R, Shi XL, et al. (2011). The roles of buyang huanwu decoction in anti-inflammation, antioxidation and regulation of lipid metabolism in rats with myocardial ischemia. Evid Based Complement Alternat Med 2011:1–8
   Google Scholar
• Ming TJ, Qiu ZS, Fang GW, et al. (2004). Ginsenoside Rg2 protection against apoptosis in ischemia and reperfusion rat myocardium. Chin Pharmaco Bull 20:480
   Google Scholar
• Mo X, Zhao N, Du X, et al. (2011). The protective effect of peony extract on acute myocardial infarction in rats. Phytomedicine 18:451–7
   PubMedGoogle Scholar
• Vaturi M, Birnbaum Y. (2000). The use of the electrocardiogram to identify epicardial coronary and tissue reperfusion in acute myocardial infarction. J Thromb Thrombolysis 10:137–47
   PubMedGoogle Scholar
• Wang T, Yu X, Qu S, et al. (2010). Effect of ginsenoside Rb3 on myocardial injury and heart function impairment induced by isoproterenol in rats. Eur J Pharmacol 636:121–5
   PubMed Web of Science ®Google Scholar
• Wang WP, Chai CZ, Kou JP, Yu BY. (2011a). Comparison of clinical indications simulating deficiency of both qi and yin syndrome induced by two types of chronic intermittent hypoxia in mice. Chin J Exp Trad Med Formu 17:171–6
   Google Scholar
• Wang YH, Qiu C, Wang DW, et al. (2011b). Identification of multiple constituents in the traditional Chinese medicine formula Sheng-Mai-San and rat plasma after oral administration by HPLC-DAD-MS/MS. J Pharm Biomed Anal 54:1110–27
   PubMedGoogle Scholar
• Wu L, Ding XP, Zhu DN, et al. (2010). Study on the radical scavengers in the traditional Chinese medicine formula Sheng-Mai-San by HPLC-DAD coupled with chemiluminescence (CL) and ESI-MS/MS. J Pharm Biomed Anal 52:438–45
   PubMedGoogle Scholar
• Wu W, Zhang XM, Liu PM, et al. (1995). Effects of panax notoginseng saponin Rg1 on cardiac electrophysiological properties and ventricular fibrillation threshold in dogs. Acta Pharmacol Sin 16:459–63
   Web of Science ®Google Scholar
• Xia R, Zhao B, Wu Y, et al. (2011). Ginsenoside Rb1 preconditioning enhances eNOS expression and attenuates myocardial ischemia/reperfusion injury in diabetic rats. J Biomed Biotechnol 2011:1–8
   Google Scholar
• Xie JT, Shao ZH, Vanden Hoek TL, et al. (2006). Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur J Pharmacol 532:201–7
   PubMed Web of Science ®Google Scholar
• Yang B, Li Y, Chen X. (1989). Correlation between protective effect of ginsenosides against myocardial ischemia and lipid peroxidation in rats. Asian Pacific J Pharmacol 4:265–72
   Google Scholar
• Yang GD, Fang ZY, Liu Y, et al. (2011). Protective effects of Chinese traditional medicine buyang huanwu decoction on myocardial injury. Evid Based Complement Alternat Med 2011:1–7
   Google Scholar
• Yang YL, Shi YR, Li JL, Chen YH. (2003). Advances in research of myocardial ischemia reperfusion injury. Adv Cardio Diseases 24:116–21
   Google Scholar
• Yellon DM, Hausenloy DJ. (2007). Myocardial reperfusion injury. N Engl J Med 357:1121–35
   PubMed Web of Science ®Google Scholar
• Yim TK, Ko KM. (1999). Schisandrin B protects against myocardial ischemia-reperfusion injury by enhancing myocardial glutathione antioxidant status. Mol Cell Biochem 196:151–6
   PubMedGoogle Scholar
• Zhan Y, Xu X, Jiang Y. (1994). Protective effects of ginsenoside on myocardiac ischemic and reperfusion injuries. Chin Med J (Engl) 74:626–8
   Google Scholar
• Zhang S, Tan SY, Li SM, et al. (2010). The origin of Sheng-Mai-San. Liaoning J Tradi Chin Med 4:1918–19
   Google Scholar
• Zhao BL, Li XJ, Liu GT, et al. (1990). Scavenging effect of schizandrins on active oxygen radicals. Cell Biol Int Rep 14:99–109
   PubMedGoogle Scholar
• Zheng C, Hao H, Wang X, et al. (2009). Diagnostic fragment-ion-based extension strategy for rapid screening and identification of serial components of homologous families contained in traditional Chinese medicine prescription using high-resolution LC-ESI-IT-TOF/MS: Shengmai injection as an example. J Mass Spectrom 44:230–44
   PubMedGoogle Scholar